Webinar Overview
Eager to master best practices, seize opportunities, and overcome challenges linked to IND submissions for gene therapy products? In this webinar, experts discuss the unique components and customizations involved in gene therapy IND submissions and study requirements.
You will learn:
- Underlying commonalities, regulations, and roadblocks as well as mitigating risk while accelerating timelines for sponsors
- Supporting the gene therapy challenges using an AAV-vectored drug candidate to cover the key imperatives of designing a nonclinical program
- Using disease models and standard species for development including species selection, route of administration, and study endpoints
Webinar Presenters
Helen-Marie Dunmore, ERT
Principal Scientific Advisor, Scientific Advisory Services
Charles River
Michael Templin, PhD
Senior Scientific Director, Scientific Advisor
Charles River
Webinar Scientific Moderator
Peter Gaskin, PhD, ERT, MTOPRA
Senior Director, Scientific Advisory Services
Charles River
Additional Information
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.